OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
53 hedge funds and large institutions have $10.2M invested in Orexigen Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
58% less capital invested
Capital invested by funds: $24.2M → $10.2M (-$13.9M)
81% less call options, than puts
Call options by funds: $72K | Put options by funds: $378K
Holders
53
Holding in Top 10
1
Calls
$72K
Puts
$378K
Top Buyers
| 1 | +$358K | |
| 2 | +$48K | |
| 3 | +$48K | |
| 4 |
Goldman Sachs
New York
|
+$31.8K |
| 5 |
Squarepoint
New York
|
+$27K |
Top Sellers
| 1 | -$2.05M | |
| 2 | -$610K | |
| 3 | -$555K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$346K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$194K |